drugset / Trial / NCT02839889
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if naloxegol can be used in the treatment of opioid-induced constipation in patients with cancer and pain. This phase 4 study consists of a two week randomized double blind period followed by a two week open-label period.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-01-11
- Completion
- 2018-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naloxegol | Small molecule | 25 mg | — |